| Features: HSP90 inhibitor |
| Radicicol, also known as monorden, is a fungal resorcylic acid lactone and natural-product HSP90 inhibitor. It binds the N-terminal ATP-binding pocket of HSP90 and inhibits its molecular-chaperone activity, resulting in destabilization and degradation of HSP90-dependent client proteins involved in tumour growth and survival. Reported effects include suppression of oncogenic kinase signalling, cell-cycle arrest, and apoptosis in experimental cancer models. Although radicicol is potent in biochemical and cell-based assays, the native compound has limited therapeutic utility because of chemical instability, rapid metabolism, and weak in-vivo activity. Reference. |
| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 6918- | FIS, | Geld, | Radic, | HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells |
| - | in-vitro, | CRC, | COLO205 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:423 Target#:961 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid